Log in

ASX:APIAustralian Pharmaceutical Industries Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
A$1.09
MA: A$1.09
A$1.09
52-Week Range N/A
Volume453,647 shs
Average Volume1.60 million shs
Market Capitalization$537.00 million
P/E Ratio10.28
Dividend Yield7.58%
BetaN/A
Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 475 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.06 out of 5 stars


Industry, Sector and Symbol

Industry Medical Equipment Wholesale
Sub-IndustryN/A
SectorServices
CUSIPN/A
CIKN/A
Phone+61-3-88553000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.07 billion
Book ValueA$1.03 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$537.00 million
Next Earnings Date10/19/2020 (Estimated)
OptionableNot Optionable

Receive API News and Ratings via Email

Sign-up to receive the latest news and ratings for API and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Australian Pharmaceutical Industries (ASX:API) Frequently Asked Questions

When is Australian Pharmaceutical Industries' next earnings date?

Australian Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Australian Pharmaceutical Industries
.

How were Australian Pharmaceutical Industries' earnings last quarter?

Australian Pharmaceutical Industries Ltd (ASX:API) posted its earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.05 by $0.00.
View Australian Pharmaceutical Industries' earnings history
.

How often does Australian Pharmaceutical Industries pay dividends? What is the dividend yield for Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries declared a final dividend on Monday, October 28th. Stockholders of record on Thursday, December 12th will be paid a dividend of 0.04 per share on Thursday, December 12th. This represents a yield of 2.93%. The ex-dividend date is Wednesday, November 13th.
View Australian Pharmaceutical Industries' dividend history
.

Has Australian Pharmaceutical Industries been receiving favorable news coverage?

Media headlines about API stock have trended extremely negative on Sunday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Australian Pharmaceutical Industries earned a daily sentiment score of -4.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about Australian Pharmaceutical Industries
.

Who are some of Australian Pharmaceutical Industries' key competitors?

What other stocks do shareholders of Australian Pharmaceutical Industries own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Austal (ASB), Mod Resources (MOD), Harvey Norman (HVN), Evolution Mining (EVN) and Downer EDI (DOW).

Who are Australian Pharmaceutical Industries' key executives?

Australian Pharmaceutical Industries' management team includes the following people:
  • Mr. Richard C. Vincent B.Bus, (Accountancy), CPA, MD, CEO & Exec. Director
  • Mr. Peter Mendo, Chief Financial Officer
  • Mr. Dean Matthews, Chief Information Officer
  • Mr. Peter F. Sanguinetti, Gen. Counsel & Company Sec. (Age 63)
  • Mr. Stephen Arthurson, Gen. Mang. of People

What is Australian Pharmaceutical Industries' stock symbol?

Australian Pharmaceutical Industries trades on the ASX under the ticker symbol "API."

How big of a company is Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries has a market capitalization of $0.00 and generates $4.07 billion in revenue each year.

What is Australian Pharmaceutical Industries' official website?

The official website for Australian Pharmaceutical Industries is www.api.net.au.

How can I contact Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries' mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000.

This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.